In order to evaluate the relationships between expression level of SPOCK2 and clinical pathological characteristics of ovarian cancer samples, we used UALCAN for differential analysis, which found that SPOCK2 was significantly associated with clinical features on transcriptional and translational levels. The gene discussed is SPOCK2; the disease is ovarian carcinoma.